According to a recent market study published by Growth Market Reports, titled, “Global Wound Irrigation Solution Market is segmented into by type, by type of wound, by application, by distribution channel and by region: Size, Share, Trends and Opportunity Analysis, 2016-2031”, the market was valued at US$ 1,500.8 million in 2022 and is expected to grow at a growth rate of 3.4% by the year 2031.

Wound irrigation is defined as the administration of a steady flow of a saline solution across an open wound before treating it. The process is done in order to achieve wound hydration, and to assist with the visual examination. Wound irrigation helps to remove deep debris and supports in cleaning wounds.

Get Sample Report @ https://growthmarketreports.com/request-sample/5220

Wound irrigation solution is formulated to sanitize injury and remove elements that affect the healing process. Examples of wound irrigation solutions include regular saline, sterile water, potable water, saline solution, and hydrogen peroxide. The solution is used in order to disinfect scratches, bruises, and other damage on the skin.

Based on type, the global wound irrigation solution market is segmented into wetting agents and antiseptics. The antiseptics segment is projected to expand at a significant CAGR during the forecast period, owing its high usage in cleaning of skin and wounds to prevent the growth of bacteria. Antiseptic solutions are used in hospitals and residential settings for minor bruises. They reduce the risk of infection during surgery and other procedures.

On the basis of type of wound, the global wound irrigation solution market is bifurcated into burns, diabetic foot ulcer, pressure ulcer, venous ulcer, surgical wounds, and others. The burns segment is anticipated to expand at a significant CAGR during the forecast period. Burn injury is painful and requires time for recovery. Regular dressing on burn injury by using the wound irrigation solution is expected to bolster the segment in the near future.

Based on application, the global wound irrigation solution market is classified into acute care hospitals, ambulatory surgical center, and wound care clinics & private offices. The wound care clinics and private offices segment is estimated to expand at a significant CAGR during the forecast period. Wound care clinics and private offices are cost-effective and provide services to patients in order to achieve speedy recovery. This is expected to drive the wound care clinics and private offices segment in the near future.

On the basis of distribution channel, the global wound irrigation solution market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The online pharmacy segment is projected to grow at a rapid pace in the coming years, owing to the inclination of consumers towards online services such as discounts and home delivery.

The outbreak of COVID-19 pandemic disrupted the global supply chain, due to lockdown measures, travel restrictions, and manufacturing disruptions. Supply chain issues led to challenges in the production and distribution of several healthcare products, causing delays in delivery and shortages in some regions. Supply chain disruptions moderately impacted the availability of essential raw materials required for manufacturing wound irrigation solution. Governments have imposed social distancing and remote working as well as shut down economic operations globally, which hampered the global wound irrigation solution market.

Increasing support by various governments and environmentalists through investments in the manufacture of wound irrigation solutions is expected to fuel the market post-pandemic. R&D was halted, due to social distancing laws imposed during the pandemic. A decrease in research activity, due to laboratory closures and reduced clinical testing, slightly negatively affected the Wound Irrigation Solution Market.

As per growth market reports by industry analyst Raksha Sharma, “Factors such as increase in accidents, surgeries, changing lifestyles, and the prevalence of chronic diseases play a significant role in the growth of global wound irrigation solution market.”

Supply chain management is an essential part of any business. Supply chain contains a series of steps to get products from their original state to the customers. These steps include transforming raw materials into final products, transporting those products, and distributing them to the end-users. Quality checks are performed throughout the production process by manufacturers to ensure the quality of the product. The products are then supplied to the distributors. End-users are the final step of the supply chain. End-users of wound irrigation solution include acute care hospitals, ambulatory surgical centers, and wound care clinics & private offices.

Market Key Developments

In November 2023, Sonoma Pharmaceuticals announced U.S. launch of next generation advanced solution for pulse lavage irrigation at the symposium on advanced wound care fall conference.

In July 2021, ActiMaris conducted a retrospective survey on modern wound irrigation solutions, focusing on solutions of the HOCl/NaOCl type, as part of quality assurance in certified wound care facilities.

In May 2021, BD announced the availability of BD Surgiphor Sterile Wound Irrigation System, the first and only ready-to-use aqueous povidone-iodine (PVP-I) irrigation solution that mechanically loosens and removes wound debris.

The players in the Global Wound Irrigation Solution Market include Mölnlycke Health Care AB; Smith & Nephew; Convatec; Cardinal Health; B. Braun SE; BD; MCKESSON CORPORATION; Next Science; REGENO GmbH; Schülke & Mayr GmbH; SERAG-WIESSNER GmbH & Co. KG; Argentum Medical, LLC; Irrimax Corporation; Axio Biosolutions Pvt Ltd; Zimmer Biomet; and ActiMaris AG.

Report Scope:

Report Metric

Details

Market Value in 2022

US$ 1,500.8 Million

Market Growth Rate (from 2020 to 2028)

3.4%

Historical Data

2016 & 2021

Base Year

2022

Forecast Period

2023 – 2031

Units Considered

Value (US$ Million)

Market Segments

By type, by type of wound, by application, and by distribution channel

Key Companies Profiled

Mölnlycke Health Care AB; Smith & Nephew; Convatec; Cardinal Health; B. Braun SE; BD; MCKESSON CORPORATION; Next Science; REGENO GmbH; Schülke & Mayr GmbH; SERAG-WIESSNER GmbH & Co. KG; Argentum Medical, LLC; Irrimax Corporation; Axio Biosolutions Pvt Ltd; Zimmer Biomet; and ActiMaris AG.

Customization Scope

Report customization available on request

Pricing and Purchase Options

Avail of tailor-made purchase options to meet your research requirements.


Target Audience:

  • Supply-side: Manufacturer, Suppliers and End-users.
  • Demand Side: Acute Care Hospitals, Ambulatory Surgical Center, and Wound Care Clinics & Private Offices